📖

GSK4527226 (AL101) Open-Label Extension (NCT07105709)

wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-clinical-trials-gsk4527226-al101-nc

Related Entities

clinical-trials-gsk4527226-al101-nct07105709-ole

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile

Evidence Balance

+0%

Certainty

15%

Debates

0

Incoming

3

Outgoing

15

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Linked Artifacts (18)

related🧫Cytochrome Therapeutics70%

related🧫Cytochrome Therapeutics70%

mentions🧪TREM2-mediated microglial tau clearance enhancement50%

mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%

related🔬What are the mechanisms underlying digital biomarkers and ai50%

mentions🧪APOE-TREM2 Interaction Modulation50%

related🧪Extracellular Vesicle Biogenesis Modulation50%

related🧪Lysosomal Enzyme Trafficking Correction50%

mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%

related🧪Lysosomal Positioning Dynamics Modulation50%

related🔬What are the mechanisms underlying digital biomarkers and ai50%

related🧪Mitochondrial-Lysosomal Contact Site Engineering50%

mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%

related🧪Lysosomal Calcium Channel Modulation Therapy50%

mentions🧪Ocular Immune Privilege Extension50%

related🧪Lysosomal Membrane Repair Enhancement50%

mentions🧪TREM2-Dependent Microglial Senescence Transition50%

related🧪Ocular Immune Privilege Extension40%

💬 Discussion